HTFL Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

30.280

Open

29.200

VWAP

29.48

Vol

1.09M

Mkt Cap

2.49B

Low

28.937

Amount

32.15M

EV/EBITDA(TTM)

--

Total Shares

85.76M

EV

2.31B

EV/OCF(TTM)

--

P/S(TTM)

12.20

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Show More

Events Timeline

(ET)

2026-04-13

09:10:00

Heartflow Sues Cleerly for Patent Infringement in Texas

2026-03-18 (ET)

2026-03-18

18:30:00

US Stocks Drop on Iranian Energy Attacks and Inflation Data

2026-03-18

16:20:00

Heartflow Q4 Revenue $49.13M Beats Expectations

2026-03-18

16:20:00

Sees FY26 Gross Margin at 80%-81%

2026-03-16 (ET)

2026-03-16

08:10:00

Heartflow Launches New Clinical Evidence and Registry

2026-02-12 (ET)

2026-02-12

08:10:00

Heartflow Expands GAMEFILM Registry to Include NBA and NHL Athletes

News

Yahoo Finance

04-14Yahoo Finance

CEO John C.M. Farquhar Sells 22,562 Shares in Hear

seekingalpha

04-13seekingalpha

Heartflow Files Patent Infringement Lawsuit Against Cleerly

PRnewswire

03-27PRnewswire

Heart Disease Crisis Fuels AI Diagnostic Platforms

Newsfilter

03-27Newsfilter

Heart Disease Crisis Fuels AI Diagnostic Platforms

Fool

HeartFlow Executive Stock Transaction Overview

NASDAQ.COM

03-25NASDAQ.COM

HeartFlow CMO Executes Options and Sells Shares

5 Analyst Rating

Wall Street analysts forecast HTFL stock price to rise

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

35.00

Averages

38.60

High

40.00

Current: 0.000

Low

35.00

Averages

38.60

High

40.00

Canaccord

Buy

maintain

$40 -> $43

AI Analysis

2026-03-19

Reason

Canaccord

Price Target

$40 -> $43

AI Analysis

2026-03-19

maintain

Buy

Reason

Canaccord raised the firm's price target on Heartflow to $43 from $40 and keeps a Buy rating on the shares. The firm said HeartFlow reported a solid Q4 beat and gave initial 2026 guidance that they believe is highly conservative given the expected momentum its ongoing Plaque Analysis launch should have.

JPMorgan

Robbie Marcus

Overweight

downgrade

$40 -> $35

2026-03-19

Reason

JPMorgan

Robbie Marcus

Price Target

$40 -> $35

2026-03-19

downgrade

Overweight

Reason

JPMorgan analyst Robbie Marcus lowered the firm's price target on Heartflow to $35 from $40 and keeps an Overweight rating on the shares. The firm view s the company's Q4 report as good with Plaque ahead of expectations.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HTFL

Unlock Now

Valuation Metrics

The current forward P/E ratio for Heartflow Inc (HTFL.O) is 0.00, compared to its 5-year average forward P/E of -53.73. For a more detailed relative valuation and DCF analysis to assess Heartflow Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-53.73

Current PE

0.00

Overvalued PE

-44.01

Undervalued PE

-63.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-45.72

Current EV/EBITDA

-25.96

Overvalued EV/EBITDA

-22.75

Undervalued EV/EBITDA

-68.68

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

11.56

Current PS

8.64

Overvalued PS

14.81

Undervalued PS

8.31

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

stock for buy and sell today

Intellectia · 241 candidates

Market Cap: >= 500.00MPrice: $3.00 - $200.00Price Change Pct: $-50.00 - $-1.00Monthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

Bright Horizons Family Solutions Inc

4.63B

Upstream Bio Inc

691.69M

Pinterest Inc

12.52B

Fortune Brands Innovations Inc

7.48B

Draftkings Inc

22.41B

Rich Sparkle Holdings Ltd

778.75M

US MARKETS , ALL SECTORS

Intellectia · 158 candidates

Dividend Yield Ttm: >= 0Debt Equity: <= 1Pe Ttm: <= 10

Ticker

Name

Market Cap$

QXO Inc

15.83B

Bitmine Immersion Technologies Inc

13.35B

CG Oncology Inc

4.61B

SoundHound AI Inc

4.46B

Arcellx Inc

3.98B

Cal-Maine Foods Inc

3.79B

Whales Holding HTFL

Summit Partners Public Asset Management, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Heartflow Inc (HTFL) stock price today?

The current price of HTFL is 29.23 USD — it has increased 0.62

What is Heartflow Inc (HTFL)'s business?

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

What is the price predicton of HTFL Stock?

Wall Street analysts forecast HTFL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTFL is38.60 USD with a low forecast of 35.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Heartflow Inc (HTFL)'s revenue for the last quarter?

Heartflow Inc revenue for the last quarter amounts to 49.13M USD, decreased

What is Heartflow Inc (HTFL)'s earnings per share (EPS) for the last quarter?

Heartflow Inc. EPS for the last quarter amounts to -0.29 USD, decreased

How many employees does Heartflow Inc (HTFL). have?

Heartflow Inc (HTFL) has 843 emplpoyees as of April 16 2026.

What is Heartflow Inc (HTFL) market cap?

Today HTFL has the market capitalization of 2.49B USD.